{"id":"W2889540205","doi":"10.1182/bloodadvances.2018020644","title":"Ravulizumab (ALXN1210) in patients with paroxysmal nocturnal hemoglobinuria: results of 2 phase 1b/2 studies","year":2018,"lang":"en","type":"article","venue":"Blood Advances","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":85,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Paroxysmal nocturnal hemoglobinuria; Hemoglobinuria; Hemolysis; Dosing; Medicine; Internal medicine; Gastroenterology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007768365,0.001041538,0.001858705,0.0002965005,0.0003744881,0.0008571175,0.0004656989,0.001155747,0.0008180559],"category_scores_gemma":[0.002538294,0.0003588717,0.001509759,0.000356167,0.0005221516,0.0008401253,0.0002225173,0.001654859,0.0002378651],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006552432,"about_ca_system_score_gemma":0.0008541177,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007302006,"about_ca_topic_score_gemma":0.001443047,"domain_scores_codex":[0.9983211,0.00104981,0.0001520122,0.0001723168,0.0001466799,0.0001580152],"domain_scores_gemma":[0.9978179,0.0009243583,0.0004147784,0.0001410797,0.0002288763,0.0004730183],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4303592,0.03340463,0.06037223,0.002131206,0.006648644,0.00108657,0.001108706,0.001758652,0.07060541,0.0003000801,0.004011235,0.3882135],"study_design_scores_gemma":[0.2656238,0.5104883,0.2012118,0.0002322523,0.003822377,0.001653926,0.0001878626,0.001606255,0.007299414,0.0002562772,0.007513572,0.0001042628],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9775934,0.01853379,0.0007338063,0.0006882253,0.00008238349,0.0006344641,0.0003337736,0.00006257217,0.00133752],"genre_scores_gemma":[0.9909753,0.005485429,0.001002275,0.0009771176,0.000217044,0.0003178817,0.0006466547,0.00001554823,0.0003627921],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007768365,"threshold_uncertainty_score":0.04108351,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01404992659432525,"score_gpt":0.2970690898814367,"score_spread":0.2830191632871114,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}